Kenneth Galbraith, Chair & CEO at Zymeworks Inc. (ZYME), sold 60,848 shares at $22.67 ($1.4M) on 2026-01-12, disclosed to the SEC on 2026-01-12.
Open-market sale of $1.4M ZYME by Chair & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.67 | 30,424 | $690K | 50.0% |
| 2 | $22.67 | 30,424 | $690K | 50.0% |
| Total | $22.67 avg | 60,848 | $1.4M | 100% |
| Filing → |
| ZYME | SELL | 2025-01-06 | $1.7M | — | Filing → |
| ZYME | SELL | 2024-01-08 | $516K | — | Filing → |
| MGNX | SELL | 2020-09-10 | $1.1M | — | Filing → |